ArticleJournal of arthropod-borne diseases2025
Successful Therapeutic Management of Trypanosomosis in a Dog-A Case Report.
Article in Journal of arthropod-borne diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trypanosomosis is one of the most important and deadliest diseases of canines. Usually within 3 to 4 weeks an infected dog dies in the acute form of the disease. The use of inappropriate doses of anti-trypanosomatid drugs in animals leads to the development of huge resistance in the organisms. Methods: The present study communicates the successive therapeutic management of clinical trypanosomiasis with five doses of diminazine aceturate injection. One mongrel dog came with the clinical signs of persistent fever, tachycardia, severe dehydration, pale mucous membrane, corneal opacity, prolonged recumbency, and enlargement of superficial lymph nodes. A Giemsa-stained thin blood smear revealed the presence of Trypanosoma organisms. Haematobiochemical parameters revealed lowered total leucocyte count, haemoglobin, total platelet count, serum total protein, and blood glucose levels and elevated levels of alkaline phosphatase, serum creatinine, and blood urea nitrogen. Results: We observed the animal responded after the third day of post-therapy, and the clinical and haematobiochemical improvement was recorded after twenty days of post-therapy. The corneal opacity completely subsides after 28 days consequently. Conclusions: During our study we found that the proper significant dosing of diminazine aceturate can cure the Trypanosomosis in dogs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.